I
nduced sputum cell counts are a noninvasive, reliable method for evaluating the presence, type and degree of inflammation in the airways of the lungs (1) (2) (3) . Sputum cell counts have been used to assist with the management of underlying airway inflammation, including assessment of asthma control and titration of inhaled corticosteroid therapy in patients with asthma (4) . Adjusting asthma management based on sputum eosinophil counts has been found to be effective in reducing asthma exacerbations (4) (5) (6) (7) and is now considered to be standard of care for the management of difficult-to-control asthma in the Canadian asthma guidelines (8) .
Previous studies assessing the cellular profile of induced sputum in healthy subjects, compared with asthma and chronic obstructive pulmonary disease patients (9, 10) , were limited by very small sample sizes and differences in sample collection. Current reference values for absolute and percentage induced sputum cell counts in healthy adults were derived from two major studies performed >12 years ago (11, 12) . However, only the study by Belda et al (11) assessed absolute sputum cell counts. Furthermore, compared with the results from Belda et al, Spanevello et al (12) reported a lower percentage of sputum neutrophils and a higher percentage of sputum macrophages. In addition to these differences, it is unclear whether the results are generalizable to other sputum laboratories, including those in Western Canada or at elevated altitude.
In Calgary (Alberta), induced sputum collection and processing was initiated in 2005 as part of the Department of Medicine Innovation funding program. Our laboratory, located 1074 m above sea level, has been using the reference range for total sputum cell count and sputum differential cell percentages derived from Belda et al (11) . The clinical use of induced sputum testing continues to increase; to date, we have analyzed approximately 3100 clinical samples from within the Calgary region and surrounding referral areas.
Understanding whether the current reference values are applicable in other laboratories that process clinical samples will help standardize our interpretation of induced sputum cell counts in the clinical . Bland-Altman analysis and intraclass correlation coefficients revealed excellent interobserver agreement for measurement of sputum cell types. DiSCuSSion: The range of induced sputum cell counts performed in a laboratory in Western Canada in healthy nonsmoking adult subjects was described; cellular distributions were similar to previous studies. This was also the first description of normal values for formalin-fixed induced sputum samples.
ConCLuSionS:
These results confirm that current reference values for induced sputum are generalizable across different laboratories, including those in Western Canada and those at elevated altitude, and are also generalizable to formalin-fixed samples, allowing use in the broader Canadian asthma population. investigation and management of inflammatory airways disorders. The aim of the present study was to describe the normal range of induced sputum cell counts in healthy, nonsmoking adults in Calgary and compare these with current reference values. We hypothesized that the range of induced sputum cell counts would be similar to those reported by Belda et al (11) .
METhoDS

Participants
The present study was approved by the institutional research ethics board and written informed consent was obtained from all subjects. Adult study and control participants were eligible for inclusion in the study provided they were nonsmokers who had no history of any chronic respiratory conditions and had normal spirometry (forced expiratory volume in 1 s [FEV 1 ] >80% predicted and FEV 1 to forced vital capacity [FVC] ratio >0.75), with no significant bronchodilator response (FEV 1 <200 mL increase and FVC <12% increase following short-acting bronchodilator administration). Potential study participants were excluded from the study if they had any of the following: a positive methacholine challenge test (defined as a provocative concentration of methacholine required to cause a 20% reduction in baseline FEV 1 [PC 20 ] <16 mg/mL); a smoking history ≥5 pack years or had smoked within the past 12 months; a history of atopy; a history of rhinitis symptoms; an upper respiratory tract infection four weeks before study participation; or a history of any inflammatory condition considered by the investigators to be clinically relevant, including any underlying autoimmune disorder, infectious disease, immunodeficiency, malignancy or clinically relevant cardiovascular, neurological, endocrine or hematological disorder. Women who were pregnant or who were planning on become pregnant during the study period, and women who were breastfeeding were also excluded. Finally, only individuals who provided written informed consent were included in the study.
Study design
The primary objective of the present analysis was to describe the normal range of induced sputum cell counts in healthy adults attending a clinical induced sputum program in Western Canada.
Study participants attended the laboratory on three separate occasions. During the first visit, the subject's medical history was reviewed to determine whether they met the inclusion/exclusion criteria, and pre-and postbronchodilator spirometry was completed. At visit 2, subjects underwent the methacholine challenge test. Induced sputum collection was performed at visit 3.
Procedures
Pulmonary function testing: Spirometry, pre-and postbronchodilator administration, and methacholine challenge testing were performed according to American Thoracic Society guidelines (13, 14) . Sputum induction and processing: Induced sputum collection was performed using accepted techniques as per standardized guidelines (15) . Briefly, sputum was induced using escalating concentrations of hypertonic saline (4%, 4%, 5%). Subjects inhaled the hypertonic saline for 7 min for each concentration. If the baseline FEV 1 fell by >20% or if the subject experienced respiratory distress, the procedure was discontinued and treatment with inhaled bronchodilator was given. Spirometry was repeated to ensure that FEV 1 improved to within 10% of baseline. After induction, 10 mL of 10% buffered formalin (Starplex Scientific Inc, Canada) was added to the expectorated sample (16) . Samples were then processed within two to five days after collection. The expectorated preserved sputum was poured into a petri dish and examined. Mucus plugs were selected and contaminating saliva was removed. The sample was suspended in phosphate-buffered saline and rocked for 10 min before being centrifuged (500 ×g for 10 min). After centrifugation, the supernatant was removed and the sample was briefly vortexed. These steps were repeated three times. The sample was weighed, and a solution of 2.5% trypsin (three times volume to sputum weight) was added to the sample and the solution was then incubated at 37°C overnight (16 h to 17 h). Total cell counts were obtained manually using a Bright-line Neubuer hemacytometer (Hausser Scientific, USA). The cells were diluted to 1×10 6 /mL in phosphate buffered saline and cytospin slides were prepared before staining with Congo Red, after which differential sputum cell counts were performed on 400 nonsquamous cells. Cell viability could not be determined using this formalin preservation method, which was established in a previous publication by Kelly et al (17) validating this method. Samples were considered to be adequate for analysis if squamous cell contamination was <20%. Measurements were compared with standardized values (11) . Cell counts were performed by an experienced cytotechnologist blinded to subject characteristics and study protocol. To assess interobserver agreement in the differential sputum cell count, the slides from 20 subjects were re-counted by a second experienced cytotechnologist, who was also blinded to subject characteristics and the study protocol.
Statistical analyses
Sputum cell counts were expressed as arithmetic mean ± SD when normally distributed, or as median (interquartile range [IQR]) when non-normally distributed. The normal range was expressed by mean ±2 SD, as well as the median and 10th and 90th percentiles. The difference in the cell counts between men and women was assessed using independent t tests for normally distributed data and Wilcoxon ranksum test for nonparametric data. To account for multiple analyses, P<0.01 was considered to be statistically significant. The effect of spirometric measurements (absolute and per cent predicted) on sputum cell counts was assessed using linear regression. Significance was accepted at 95%. To assess interobserver agreement in the differential sputum cell count, Bland-Altman plots were performed and intraclass correlation coefficients (ICC) were calculated.
RESuLTS
Study subjects
Subject enrollment began in January 2010 and ended in March 2012. Subject flow is summarized in Figure 1 . Of the 105 subjects who volunteered to participate, 11 were excluded due to a positive methacholine challenge test, 16 were withdrawn due to difficulties attending all required study visits and nine were excluded because at least one of their sputum samples was unsatisfactory for interpretation. Sixty-nine subjects were included in the final analyses. Subject characteristics are summarized in Table 1 . The majority of the subjects were Caucasian (n=54) and female (n=43). The study population had normal spirometry. None of the subjects were taking regular medications at the time of enrollment.
induced sputum cell counts
The median sputum weight was 0.60 g (IQR 0.26 g to 1.56 g), similar to previously reported values (18) . Table 2 summarizes the induced sputum total and differential cell counts (×10 6 cells/g). Table 3 summarizes the range of induced sputum differential cell percentages. The majority of cells were neutrophils and macrophages. Sputum cell counts (cells/g and percentage) were compared according to subjects' sex and spirometric measurements (absolute values and per cent predicted) ( Table 4) . Absolute FEV 1 and FVC were higher in men but the per cent predicted measurements were not different. No significant differences in sputum cell types were found between male and female subjects. No sputum cell type showed a significant relationship with spirometric measurements.
inter-and intraobserver agreement
Sputum samples from 20 subjects were randomly selected for differential sputum cell count interpretation by a second cytotechnician blinded to subject characteristics and study protocol. Bland-Altman analysis revealed very good interobserver agreement (Figure 2 , Table 5 ). The ICC revealed excellent agreement for the cell types (Table 5) . Intraobserver agreement was performed on an additional 20 randomly selected subject samples. Bland-Altman analysis and ICC showed excellent agreement (Table 6) .
DiSCuSSion
The present study described the normal range of induced sputum cell counts performed in a laboratory in Western Canada involving healthy, nonsmoking adult subjects and found cellular distributions to be similar to previous studies (11, 12) . We extended the observations from those studies by performing interobserver agreement for interpretation of the differential sputum cell count and confirmed that the results were reliable. Furthermore, the present report is the first to describe normal values for formalin-fixed induced sputum samples.
The median total sputum cell count in our study fell between the median values from the studies by Belda et al (11) and Spanevello et al (12) . Although the sputum absolute and percentage cell counts most closely resembled those of Belda et al (11) , the total and absolute neutrophil cell counts were lower in our study, in addition to variability in these cell counts. We found a slightly lower percentage neutrophil count. Eosinophil cell counts (absolute and percentage) were only slightly higher in our study, as was the variability in the range of these values. Macrophage cell counts were lower, while lymphocyte and bronchial epithelial cell counts were only slightly higher. Compared with the findings reported by Spanevello et al (12) , our results showed a higher percentage of sputum neutrophils and a lower percentage of macrophages. The differences may be a result of the formalin fixation method used in our study. Formalin is believed to rapidly inactivate cellular enzymes and stabilize the cell membrane when added to induced sputum samples (17) . It is possible that use of the preservation technique may have improved cell viability and cellular recovery compared with previous studies reporting normal cell count values. Similar to Belda et al (11), we found no significant relationship with sputum cell counts and spirometric measurements. There was also no difference in absolute or percentage sputum cell counts between male and female subjects. Our results differ from those of Belda et al (11) , who found that absolute and percentage eosinophil counts were higher in females (absolute counts: mean difference 0.003×10 6 cells/g [95% CI 0.000% to 0.015%]; P=0.049; percentage counts: 0.274% [95% CI 0.001% to 0.651%]; P=0.043). Our study had fewer subjects and may have been underpowered to detect this subgroup difference. In addition to providing a normal dataset for Western Canada and for induced sputum laboratories located at elevated altitudes, the present report is the first to describe normal values for formalin-fixed induced sputum samples. The use of formalin as a preservation method for induced sputum processing has previously been validated (17) . Specifically, Kelly (19) compared two methods of sputum processing: a (para)formaldehyde-dithiothreitol (DTT) mixture dispersed with trypsin (preservation method); and immediate processing with DTT (routine method). Good agreement between the techniques was found, along with good within-method repeatability for the preservation method, thereby confirming that this method is valid and reliable. Furthermore, no increase in degenerative changes and no interference of cell counts by debris were found (19) . This technique has subsequently been successfully used to process sputum samples in a remote collection site (20) . Additionally, this method of preservation has been shown to have no adverse effect on sample quality and sputum cell counts (16) . Use of this preservation technique allows sites that are unable to process sputum to store the sample and send it to a central processing laboratory. This would allow expanded use of induced sputum cell counts, including in rural communities, and make the recent Canadian Thoracic Society asthma guideline recommendation to use sputum cell counts in managing moderate-severe asthma more generalizable to the broader Canadian asthma population. Viability of the preserved cells could not be determined. The standard method of measuring cell viability using the trypan blue exclusion technique (21) was not possible because addition of formalin resulted in cell death. Formalin-preserved cells have good morphology and cell counts, total and differential, and may be performed in the same way as the DTT method (17) .
There were a few limitations to the present study. First, our sample size was smaller than the studies from which the current induced sputum cellular reference values were derived. The smaller sample size likely contributed to the higher variability in some of the cell counts (absolute and percentage) compared with previous literature. Despite this, our results were similar to those studies. Second, although subjects with a history of atopy were excluded, we did not perform allergy skin prick testing on all study subjects. Thus, it is possible that some patients may have had latent atopy with no clinical history. Third, due to the preservation technique, we were not able to assess sputum fluidphase mediators such as sputum cytokines.
